$36.11
+0.91 (+2.59%)
Open$35.98
Previous Close$35.20
Day High$36.24
Day Low$35.80
52W High$54.85
52W Low$20.85
Volume—
Avg Volume1.27M
Market Cap1.35B
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-31.8% upside
Current
$36.11
$36.11
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 207.42M | 147.98M | 753.50M |
| Net Income | -18,163,334 | -11,662,267 | 117.60M |
| Profit Margin | -8.8% | -8.3% | 15.6% |
| EBITDA | 10.90M | 7.39M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +40.2% | +40.2% | +23.8% |
| Debt/Equity | 3.15 | 3.15 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |